Correlation Between HCW Biologics and Molecular Templates
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Molecular Templates at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Molecular Templates into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Molecular Templates, you can compare the effects of market volatilities on HCW Biologics and Molecular Templates and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Molecular Templates. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Molecular Templates.
Diversification Opportunities for HCW Biologics and Molecular Templates
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Molecular is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Molecular Templates in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Templates and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Molecular Templates. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Templates has no effect on the direction of HCW Biologics i.e., HCW Biologics and Molecular Templates go up and down completely randomly.
Pair Corralation between HCW Biologics and Molecular Templates
Given the investment horizon of 90 days HCW Biologics is expected to generate 1.49 times more return on investment than Molecular Templates. However, HCW Biologics is 1.49 times more volatile than Molecular Templates. It trades about 0.09 of its potential returns per unit of risk. Molecular Templates is currently generating about 0.02 per unit of risk. If you would invest 46.00 in HCW Biologics on August 29, 2024 and sell it today you would earn a total of 10.00 from holding HCW Biologics or generate 21.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Molecular Templates
Performance |
| Timeline |
| HCW Biologics |
| Molecular Templates |
HCW Biologics and Molecular Templates Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Molecular Templates
The main advantage of trading using opposite HCW Biologics and Molecular Templates positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Molecular Templates can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Templates will offset losses from the drop in Molecular Templates' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Molecular Templates vs. Valneva SE ADR | Molecular Templates vs. Bright Minds Biosciences | Molecular Templates vs. HP Inc | Molecular Templates vs. Intel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |